94
Views
7
CrossRef citations to date
0
Altmetric
Original Research

The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse

, , , , , & show all
Pages 339-347 | Published online: 24 Jan 2019

Abstract

Background

Alcohol dependence displays a wide variety of clinical phenotypes. Various typology classifications of alcoholism include age of onset of alcohol abuse as one of the major phenotypic features. Serotonergic changes have been associated with alcoholism, while serotonin receptors type 1B (5-HT1B) play an important role in regulating serotonergic neurotransmission. The rs13212041 polymorphism modulates the expression of HTR1B gene coding for 5-HT1B receptor. This study examined the association of platelet serotonin (5-HT) and HTR1B gene with the onset of alcohol abuse in alcohol-dependent subjects.

Materials and methods

Determination of platelet 5-HT concentration and genotyping of rs13212041 HTR1B gene polymorphism were performed in 613 alcohol-dependent patients, subdivided according to early/late onset (before/after 25 years of age) of alcohol abuse.

Results

Alcohol-dependent individuals with CC genotype were more frequent in the group with early onset of alcohol abuse compared to carriers of T allele. Besides HTR1B genotype, age and gender, but not platelet 5-HT, were major variables associated with the onset of alcohol abuse. Platelet 5-HT concentration was not significantly different between patients with early and late onset of alcohol abuse, or patients carrying various HTR1B genotypes. Although we observed no influence of co-variables such as age, gender, or somatic and psychiatric comorbidities, platelet 5-HT concentration was significantly affected by smoking.

Conclusion

These findings support potential involvement of 5-HT1B receptors in the onset of alcohol abuse and development of alcohol dependence. Additionally, the results of our study emphasize the importance of controlling for smoking status, as one of the significant confounding factors influencing platelet 5-HT concentration.

Introduction

Patients with alcohol dependence display individual differences in clinical symptoms and phenotypic characteristics, including disease severity, course and prognosis, comorbidity, and treatment response, which may be the result of different underlying neurobiological mechanisms, such as genetic and environmental influences.Citation1,Citation2 In order to reduce the heterogeneity of this complex disease, different authors proposed various typology classifications to divide alcohol-dependent subjects into more specific subtypes or endophenotypes.Citation3 Many proposed classifications of alcohol dependence include the age of onset of alcohol abuse as one of the major phenotypic features with potential usefulness in elucidating underlying neurobiological pathways and improvement of the therapy.Citation4,Citation5 The age of onset of alcohol abuse might be due to the individual’s genetic predisposition, as well as to a number of environmental factors.Citation6 The Cloninger classification,Citation7 among the most widely used classification schemes for alcohol dependence,Citation8 also uses onset of alcohol abuse to differentiate between alcohol-dependent subjects type I and II, which differ in the course of the disease, extent of inheritance, and personality traits.Citation9

Subjects with an early onset (before 25 years of age) of alcohol abuse (type II alcoholism) are more likely to drink heavily, to have more alcohol-related problems, more severe symptoms, and higher rates of somatic and psychiatric comorbidity.Citation4,Citation10 In addition, early onset alcoholism has been often associated with elevated levels of antisocial behavior and delinquency during adolescence and characterized as strongly heritable and male-limited.Citation7 These subjects use alcohol for its euphoric effects and demonstrate high novelty seeking and low harm-avoidance personality traits.Citation11 On the other hand, type I alcoholics have later onset of alcohol abuse (after 25 years of age) and are more strongly influenced by social environmental factors. Moreover, alcoholism with later onset affects both men and women, who drink alcohol for its anxiolytic properties and have high harm-avoidance personality traits.Citation7 These two subtypes of alcohol-dependence are suggested to have different neurobiological backgrounds. Namely, it has been proposed that type I and type II alcohol-dependent individuals, differing in the age of alcoholism onset, have a deficit in the dopaminergic or serotonergic neurotransmission, respectively.Citation12 This has been supported by studies demonstrating that type II alcoholics seem to have reduced levels of serotonin transporter (5-HTT) already in early age, whereas in type I alcoholics, the serotonergic alterations may be secondary and possibly reflecting the alterations in the dopaminergic system.Citation13,Citation14

Variations in the 5-HTT geneCitation15 and tryptophan hydroxylase geneCitation16 have been associated with an increased risk of alcohol dependence with an early onset as well as with alcohol treatment response.Citation17 Moreover, decreased serotonergic neurotransmissionCitation18 and reduced concentrations of 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of serotonin (5-HT), have been found in the cerebrospinal fluid of early onset alcohol-dependent subjects.Citation19 Low plasma ratio of tryptophan to large neutral amino acids (TRYP/LNAA ratio), a marker of serotonergic function, has also been observed in patients with an early onset of alcohol dependence.Citation20 The findings suggest that these individuals might have a preexisting 5-HT deficit and therefore increased vulnerability to fluctuations in precursor availability, leading to higher alcohol intake early in life.Citation10 In line with these results, low activity of monoamine oxidase (MAO), the enzyme degrading 5-HT, has been associated with type II subtype of alcoholism.Citation21 In addition, the classification based on the age of onset of alcohol abuse seems to be an effective predictor of treatment response to various serotonergic drugs.Citation22 Namely, ondansetron has been useful in therapy of early onset alcoholic patients,Citation23 whereas sertraline has shown positive effects in the late onset alcohol-dependent subjects.Citation24 Conversely, fluoxetine reduced the beneficial effects of cognitive–behavioral therapy in early onset alcoholics.Citation25

The involvement of 5-HT system in the onset-based alcoholism typologies has been supported by both animal and human studies demonstrating that serotonergic disturbances have been closely related to reduced inhibitory control of behavior, including extensive alcohol use.Citation10,Citation26 Low central serotonergic activity has been mostly associated with increased alcohol consumption and alcohol dependence.Citation26 Central 5-HT type 1B (5-HT1B) receptors have an important role in the physiologic synaptic feedback mechanism and regulation of serotonergic neurotransmissionCitation27 and are involved in various neurological disorders such as migraine.Citation28 Moreover, 5-HT1B receptors have been suggested to modulate the activity of dopaminergic neurons in the ventral tegmental area, which is involved in the reward mechanisms underlying addictions, including alcohol dependence.Citation29 Various animal studies have also implicated 5-HT1B receptor in the control of alcohol preference and consumption.Citation30,Citation31

Previous human studies reported the associations between different polymorphisms in the gene coding for 5-HT1B receptor (HTR1B) and alcohol dependence,Citation32,Citation33 especially alcoholism with early onset and antisocial behavior.Citation4,Citation34,Citation35 The majority of reports assessing the association of HTR1B gene and alcoholism investigated G-861C polymorphism,Citation33,Citation34 which is in strong linkage disequilibrium with other functional polymorphisms in the HTR1B gene promoter, such as T-261G, A-161T, and C-129T.Citation33,Citation36,Citation37 On the other hand, other authors failed to confirm these findings,Citation37Citation39 perhaps due to the variability of alcohol-dependent phenotypes. However, only few studies investigated rs13212041 polymorphism, shown to modulate HTRIB gene expression,Citation40 and its role in alcohol dependence.Citation41,Citation42

As the majority of peripheral 5-HT is stored in platelets, which possess many other components of serotonergic system, including 5-HTT, MAO-B as well as 5-HT1A, 5-HT2A, 5-HT3A, and 5-HT4 receptors,Citation43Citation48 platelets are suggested as a limited peripheral model of central serotonergic functions.Citation49 Moreover, some reports indicated that human platelets also contain 5-HT1B receptors,Citation50 although their function in platelets is not known. However, since upon activation, platelets release 5-HT into circulation,Citation51 one might speculate that similar to its role in the brain, platelet 5-HT1B receptors might regulate 5-HT levels at the periphery. It is generally accepted that serotonergic components in both platelets and neurons are encoded by the same genes and have similar structural and functional properties.Citation52,Citation53 Hence, the rs13212041 HTR1B gene polymorphism via its influence on the 5-HT1B receptor expression might subsequently affect central as well as peripheral 5-HT turnover.

In order to investigate potential changes in the serotonergic activity associated with different alcoholism subtypes, the aim of this study was to examine the association of platelet 5-HT and rs13212041 HTR1B gene polymorphism, with the early/late onset of alcohol abuse in alcohol-dependent subjects. To our knowledge, this is first such study, with appropriate sample size and carefully determined alcohol-related phenotypes, including possible confounding factors. The findings of our study might provide novel insights in the serotonergic regulation mechanisms underlying the early/late onset of alcohol abuse, which could help in further differentiation of alcoholism subtypes and potential improvement of the therapy for this complex disease.

Materials and methods

Subjects

The study enrolled 613 medication-free patients (499 males and 114 females) with alcohol dependence, recruited from the Center of Alcoholism and Other Addictions, University Psychiatric Hospital Vrapce, Zagreb, Croatia. Patients with alcohol dependence were admitted to hospital due to acute intoxication or alcohol-related withdrawal symptoms, and were left overnight to sober up. Demographic and clinical characteristics of the alcohol-dependent patients are listed in . The alcohol dependence as well as comorbid psychiatric disorders were diagnosed using a structured clinical interview (SCID), based on the DSM-IV criteria.Citation54 If alcohol-dependent patients had any other comorbid substance abuse or dependence (except nicotine addiction) or had used any kind of drugs in the previous 12 months, they were excluded from the study. The alcohol-dependent patients were divided according to the onset of alcohol abuse into subjects with early (before 25 years of age) and late (after 25 years of age) onset of alcohol abuse.Citation7 The data regarding somatic history, including current somatic complaints, were collected from hospital medical records and obtained by an interview. Participants were Caucasians of the European origin from Zagreb County, Croatia, and they all agreed to give a blood sample, participate in the study, and gave their written informed consent. The study was approved by the Ethics Committee of University Psychiatric Hospital Vrapce, Zagreb, Croatia and carried out in accordance with the Helsinki Declaration (1964).

Table 1 The demographic and clinical characteristics of alcohol-dependent patients

Blood collection and processing

The samples of blood (8 mL) from alcohol-dependent patients were collected in the morning after overnight fasting by using a plastic syringe containing 2 mL anticoagulant (acid citrate dextrose). The whole blood was centrifuged at 1100 g for 3 minutes at 4°C. Obtained platelet-rich plasma was further centrifuged at 5087 g for 15 minutes, 4°C to sediment the platelets. The platelet pellet was washed with saline and centrifuged again. The obtained pellet was stored at −20°C.

Platelet 5-HT measurement

Platelet 5-HT concentration was measured by the spectrofluorometric method.Citation55 Briefly, platelets were broken down by sonication. Specimens of standard, blank (water), and platelet sonicates were analyzed in duplicates. All samples were deproteinized with 10% ZnSO4 and 1N NaOH, and then 0.1% L-cysteine and 0.05% orthophthalaldehyde were added for the preparation of fluorophore. The 5-HT fluorescence was measured on a Varian Spectrophotofluorimeter Cary Eclipse (Varian Optical Spectroscopy Instruments, Mulgrave, VIC, Australia) (exciting wavelength: 345 nm; emitted wavelength: 485 nm). Protein concentrations in platelets were determined by the method of Lowry et al.Citation56

Genotyping

Genomic DNA was isolated from peripheral blood leukocytes by a salting out method.Citation57 Genotyping was performed according to the procedure described by Applied Biosystems, using TaqMan-based allele-specific polymerase chain reaction on ABI Prism 7000 Sequencing Detection System apparatus. The rs13212041 (C__32252506_10) single nucleotide polymorphism in the HTR1B gene, located on chromosome 6, was analyzed. Briefly, 20 ng of genomic DNA was PCR amplified in 96-well plates using a 10 µL reaction volume. The conditions of PCR reaction were: 40 cycles at 92°C for 15 seconds and 60°C for 60 seconds.

Data analyses

Statistical analyses were performed with GraphPad Prism version 4.00 for Windows (GraphPad Software, Inc., San Diego, CA, USA) and MedCalc Statistical Software version 14.8.1 (MedCalc Software bvba, Ostend, Belgium). Normality of distribution was assessed with the D’Agostino–Pearson omnibus normality test. Age of male and female subjects enrolled in the study was compared using Student’s t-test. The frequency of smoking and early/late onset of alcohol abuse between male and female alcohol-dependent patients was evaluated by a chi-squared test of independence. Platelet 5-HT concentrations were analyzed by Kruskal–Wallis test followed by Dunn’s multiple comparison test or with Mann–Whitney test, as normality of the data failed. Possible deviations from Hardy–Weinberg equilibrium (HWE) were tested using goodness of fit chi-squared test. Genotype and allele frequencies (presented as numbers and percentages) were evaluated by a chi-squared test of independence. Multiple regression analysis assessed the influence of various demographic and clinical data (independent variables), such as age, gender, smoking, somatic and psychiatric comorbidities, on alcohol abuse onset and platelet 5-HT concentration (dependent variables).

G*Power 3 SoftwareCitation58 was used for conducting power analyses, ie, to determine a priori sample size and to post hoc compute the achieved power. For F test (Kruskal–Wallis test) involving three groups (with α=0.025; power =0.80; a small effect size =0.30), total desired sample size was 132. For F test (Kruskal–Wallis test), evaluating four groups (with α=0.025; power =0.80; a small effect size =0.30), total desired sample size was 152. For Mann–Whitney test (with α=0.025; power =0.80; a median effect size =0.30), total desired sample size was 368. For analyses with a χ2-test (with α=0.025; power (1-β)=0.80 and a small effect size (ω=0.20)), for df =2 total desired sample size was 288, and for df =1, total desired sample size was 238. As the actual total sample size was 613, the power analysis revealed that the study included appropriate sample size and statistical power to detect significant differences.

Results

Alcohol-dependent participants were predominantly male (81.40%). The group of female subjects with alcohol dependence (51.89±11.62) was significantly older (t=2.42, df =611, P=0.016; Student’s t-test) than the group of male patients (49.32±9.89). There were no significant differences in frequency of smoking (χ2=2.01, df =1, P=0.148) between male (61.72%) and female (54.39%) alcohol-dependent patients. Our study demonstrated that 395 (64.44%) of alcohol-dependent patients (67.13% of males and 52.63% of females) had some somatic comorbidity, with liver diseases present in 386 (62.97%) of enrolled subjects. Hence, most (92.72%) somatic diseases in subjects with alcoholism were liver diseases. Moreover, 279 (45.51%) alcohol-dependent patients, ie, 223 (44.69%) males and 56 (49.12%) females reported some psychiatric comorbidity. These psychiatric comorbidities include personality disorders (49.10%), stress-related disorders (37.27%) including anxiety, acute stress reaction and post-traumatic stress disorder, mood disorders (12.19%) primarily depression, and psychotic disorders such as schizophrenia (1.43%). There were no significant differences in the frequency of psychiatric comorbidities between male and female patients (χ2=0.73, df =1, P=0.391); however, male patients (67.13%) had more often somatic comorbidities (χ2=8.52, df =1, P=0.0035) than female patients (52.63%).

As shown in , alcohol-dependent subjects enrolled in the study had more often late (64.93%) rather than early (35.07%) onset of alcohol abuse. However, we observed significantly lower frequency of female patients with early, rather than with late, onset of alcohol abuse in comparison with male subjects (χ2=15.30, df =1, P<0.0001). Moreover, there were significantly more smokers in the group of early-onset alcoholics than in subjects with late onset of alcohol abuse (χ2=6.94, df =1, P=0.008). There were no significant differences in the frequency of somatic comorbidities (χ2=3.47, df =1, P=0.062) or liver diseases (χ2=3.31, df =1, P=0.069) between patients with early and late onset of alcohol abuse. However, early onset alcohol-dependent subjects more often had psychiatric comorbidities (52.09%) than patients with late onset alcohol abuse (41.96%) (χ2=5.78, df =1, P=0.016), although they did not differ in frequency of depression (χ2=0.51, df =1, P=0.477) ().

Genotype distributions for rs13212041 HTR1B polymorphism in alcohol-dependent subjects were in HWE (χ2=0.03, P=0.866). No significant differences in the frequency of the genotypes (χ2=2.13, df=2, P=0.344) or alleles (χ2=1.98, df =1, P=0.160) between male and female alcohol-dependent patients were detected using χ2-test (); therefore, in further analysis, patients were not divided according to gender. The genotype distribution for HTR1B gene polymorphism was significantly different (χ2=7.54, df =2, P=0.023) between patients with early and late onset of alcohol abuse (). Namely, the individuals carrying the CC genotype were significantly more frequent (χ2=7.25, df =1, P=0.007) in the group of alcohol-dependent subjects with early onset of alcohol abuse than in carriers of T allele. This strong evidence of HTR1B was also confirmed using multiple regression analysis (P=0.024), with age (P<0.0001) and gender (P=0.001) as major variables influencing the onset of alcohol abuse.

Table 2 Genotype and allele counts and frequencies of rs13212041 HTR1B gene polymorphism in alcohol-dependent patients subdivided according to the gender and early/late onset of alcohol abuse

As recent analysis suggested that the early onset of alcohol dependence is best defined as beginning before the age of 22 years,Citation5 we additionally divided alcohol-dependent patients into subjects with early and late onset of alcohol abuse by using cut-off point at 22 years. Although the number of patients with early onset of alcohol abuse was, in this case, significantly lower (N=107), the results obtained after making cut-off at 22 years supported and even strengthened the findings obtained with cut-off at 25 years. Both the genotype (χ2=12.07, df=2, P=0.0024) and allele (χ2=8.456, df=1, P=0.0036) distribution for HTR1B gene polymorphism was significantly different between patients with early and late onset of alcohol abuse. Namely, the individuals carrying the CC genotype (χ2=10.63, df =1, P=0.0011) or C allele (χ2=4.269, df =1, P=0.0388) were significantly more frequent in the group of alcohol-dependent subjects with early onset of alcohol abuse than in carriers of the T allele or TT genotype, respectively.

Platelet 5-HT concentrations (mean±SD) were not significantly different between male (0.84±0.49) and female (0.75±0.46) alcohol-dependent subjects (U=25795, df =611, P=0.121; Mann–Whitney test). Moreover, the Kruskal–Wallis test failed to detect any significant differences in platelet 5-HT concentration between carriers of CC (0.84±0.46), CT (0.79±0.48), or TT (0.84±0.48) HTR1B rs13212041 genotypes, in the whole sample of alcohol-dependent patients (H=1.556, df=610, P=0.459), as well as when alcohol-dependent patients were subdivided into subjects with early and late onset of alcohol abuse (H=6.643, df =607, P=0.249).

Significant differences in platelet 5-HT concentrations were found between alcohol-dependent patients with early (0.88±0.48) and late (0.79±0.48) onset of alcohol abuse (U=38035, df=611, P=0.023; Mann–Whitney test; ), and when these patients were additionally subdivided according to smoking status (H=36.49, df =609, P<0.0001; Kruskal–Wallis ANOVA; ). However, as shown in , the results of post-hoc Dunn’s multiple comparison test revealed significant differences only between smokers and nonsmokers, both in the group with early (P=0.0004) and late (P=0.0005) onset of alcohol abuse, suggesting an effect of smoking on platelet 5-HT concentration. There were no significant differences in platelet 5-HT levels between smokers with early and late onset of alcohol abuse (P=0.309) or between nonsmokers with early and late onset of alcohol abuse (P>0.9999) (Dunn’s multiple comparison test; ). Multiple regression analysis also confirmed that there was no association of platelet 5-HT levels (P=0.104) with the onset of alcohol abuse. Therefore, observed differences in platelet 5-HT concentrations between alcohol-dependent patients with early and late onset of alcohol abuse were probably due to higher frequency of smokers in the group of alcoholics with early onset of alcohol abuse.

Figure 1 Platelet 5-HT concentration in alcohol-dependent smokers and nonsmokers subdivided according to the early/late onset of alcohol abuse.

Note: *P<0.0005 smokers vs nonsmokers (Kruskal–Wallis test and post-hoc Dunn’s multiple comparison test).
Figure 1 Platelet 5-HT concentration in alcohol-dependent smokers and nonsmokers subdivided according to the early/late onset of alcohol abuse.

Our findings also suggested that there was significant difference in the smoking frequency between alcohol-dependent subjects with and without comorbid depression (χ2=6.71, df=1, P=0.0096; χ2-test). Namely, 81.82% of alcohol-dependent subjects with comorbid depression were smokers in comparison with 59.14% smokers in the group of alcoholic patients without comorbid depression. However, there was no significant difference in the frequency of comorbid depression between patients with early and late onset of alcohol abuse (), as well as no significant difference in the platelet 5-HT concentration between alcohol-dependent subjects with (0.94±0.57) and without (0.81±0.48) comorbid depression (U=8368, df=611, P=0.2257; Mann–Whitney test). In general, we observed no significant differences in platelet 5-HT concentration between alcohol-dependent patients with and without psychiatric (U=45371, df=611, P=0.576; Mann–Whitney test) as well as somatic comorbidities (U=42972, df=611, P=0.969; Mann–Whitney test).

Finally, multiple regression analysis demonstrated no significant influence of age (P=0.632), gender (P=0.270), onset of alcohol abuse (P=0.157), HTR1B rs13212041 genotype (P=0.473), somatic (P=0.584), and psychiatric comorbidities (P=0.993), but significant effect of smoking (P<0.0001) on platelet 5-HT concentration in patients with alcoholism.

Discussion

The main finding of our study is an association of rs13212041 HTR1B gene polymorphism with an onset of alcohol abuse in alcohol-dependent patients, demonstrating that homozygous individuals with CC genotype were more frequent in the group with early onset of alcohol abuse compared to carriers of T allele. Besides HTR1B genotype, age and gender, but not platelet 5-HT, were major variables influencing the onset of alcohol abuse. Platelet 5-HT concentration was not significantly different between subjects with early and late onset of alcohol abuse as well as between patients carrying different HTR1B genotypes. Although we observed no influence of co-variables such as age, gender, or somatic and psychiatric comorbidities, platelet 5-HT concentration was significantly affected by smoking.

Only few studies investigated the association of rs13212041 HTR1B gene polymorphism with alcohol dependence,Citation41,Citation42 but not with early- and late-onset alcoholism subtypes. This transition substitution (A1997G) in the distal 3′-untranslational region (UTR) of HTR1B messenger RNA disrupts a binding site for the microRNA, miR-96.Citation40 MiR-96 is expressed in the brain,Citation59 and various environmental factors, such as stress,Citation60 can modulate its expression and epigenetically underlie some of the diversity in human behavior,Citation40 including alcoholism endophenotypes. As A-allele carriers of rs13212041 HTR1B gene polymorphism demonstrate reduced HTR1B expression compared to G-allele carriers,Citation40 we can presume that subjects with early onset of alcohol abuse, more frequently carrying the CC genotype, have higher levels of 5-HT1B receptors than patients with late onset of alcohol abuse.

In general, alcohol dependence has been associated with increased density of 5-HT1B receptors in specific brain regions.Citation61 5-HT1B receptors have been shown to modify the effects of alcohol and regulate its voluntary intake,Citation62 whereas 5-HT1B receptor ligands reduce extensive alcohol drinking and alcohol-related aggressive or impulsive behavior, observed in more severe forms of alcohol dependence.Citation31,Citation63 Therefore, our findings might suggest increased expression of 5-HT1B receptors in more severe types of alcoholism, characterized with an early onset of alcohol abuse.

Our results demonstrating that early onset alcohol-dependent patients more often have psychiatric comorbidities agree with findings that these subjects have more alcohol-related problems, more severe symptoms, and higher rates of somatic and psychiatric comorbidity.Citation4,Citation10 In our study, besides HTR1B genotype, age and gender were major variables influencing the onset of alcohol abuse. This is not surprising as male patients were younger and more often present in the group with an early onset of alcohol abuse, in line with suggestions that type II alcoholism is male predominant.Citation7

The HTR1B rs13212041 polymorphism, by influencing 5-HT1B receptor expression, can subsequently affect 5-HT turnover. Namely, 5-HT1B receptors function as inhibitory autoreceptors or heteroreceptors on both serotonergic and non-serotonergic neurons, and modulate serotonergic activity. However, despite presumably higher density of 5-HT1B receptors in early-onset alcoholics, platelet 5-HT concentrations did not differ between patients with early and late onset of alcohol abuse, suggesting no association of platelet 5-HT with the onset of alcohol abuse.

Many components of serotonergic system, such as 5-HTT, MAO, and some 5-HT receptors, in both platelets and neurons are encoded by the same genes and have similar structural and functional properties.Citation52,Citation53 However, the role of 5-HT1B receptors might differ depending upon their specific location.Citation64 In addition, activation of presynaptic 5-HT1B receptors inhibits 5-HT release, while 5-HT1B postsynaptic heteroreceptors are involved in the modulation of addictive behaviors.Citation65 Therefore, platelet 5-HT1B receptors might not regulate 5-HT concentration in platelets, or their function could be affected by other 5-HT receptorsCitation66,Citation67 or interaction with 5-HTT.Citation68 No differences in platelet 5-HT levels, between carriers of different HTR1B rs13212041 genotypes in all alcohol-dependent patients, as well as in subjects with early and late onset of alcohol abuse, suggest that this polymorphism does not influence platelet 5-HT concentration.

Although previous studies found decreased platelet 5-HT concentration in alcohol-dependent subjects,Citation69Citation71 only one small study reported higher platelet 5-HT uptake in subjects with early than with late-onset of alcohol dependence, suggesting differences in platelet 5-HTT function.Citation72 However, in this study as well as these in many other studies, somatic and psychiatric comorbidities and tobacco smoking have been neglected as confounding factors, in spite of reports suggesting their effects on platelet 5-HT.Citation49,Citation73 We observed no significant influence of somatic and psychiatric comorbidities, including depression, but smoking significantly affected platelet 5-HT levels in alcohol-dependent patients in our present and previous study.Citation74 In agreement with previous results,Citation71 we detected higher platelet 5-HT concentrations in smoking alcoholics than in alcohol-dependent subjects who did not smoke. Patkar et alCitation75 reported correlation of smoking with decreased density of platelet 5-HTT sites, whereas various studies reported metabolic effects of smoking on the breakdown of dopamine and 5-HT,Citation76,Citation77 as well as decreased platelet MAO-B activity due to cigarette smoking.Citation78,Citation79

In addition to appropriate sample size and statistical power, other advantages of this study include ethnically homogenous and medication-free alcohol-dependent patients and carefully determined specific alcohol-related phenotypes, including somatic and psychiatric comorbidities and other potential confounding factors such as age, gender, and smoking. However, one of the study limitations is a lack of replication of obtained results in the independent sample.

Conclusion

As far as we know, this is the first study reporting the association of rs13212041 polymorphism, located in the HTR1B gene coding for 5-HT1B receptor, with the onset of alcohol abuse in alcohol-dependent subjects. Our results suggest that homozygous individuals with CC genotype are more likely to develop a more severe form of alcoholism, characterized by the early onset of alcohol abuse, than carriers of T-allele. As rs13212041 polymorphism affects microRNA regulation of HTR1B gene expression, these data might suggest the involvement of epigenetic mechanisms in the modulation of serotonergic functions in alcohol dependence. Our findings might provide novel insights in the serotonergic regulation mechanisms underlying the early/late onset of alcohol abuse, which could help in further differentiation of alcoholism subtypes and potential improvement of the therapy for this complex disease. The results of our study also emphasize the importance of controlling for various confounding factors, such as smoking, which significantly influence platelet 5-HT levels.

Disclosure

The authors report no conflicts of interest in this work.

References

  • EnochMAGenetic and environmental influences on the development of alcoholism: resilience vs. riskAnn N Y Acad Sci20061094119320117347351
  • LittenRZRyanMLFalkDEReillyMFertigJBKoobGFHeterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatmentAlcohol Clin Exp Res201539457958425833016
  • LeggioLKennaGAFentonMBonenfantESwiftRMTypologies of alcohol dependence. From Jellinek to genetics and beyondNeuropsychol Rev200919111512919184441
  • ChenYCPrescottCAWalshDDifferent phenotypic and genotypic presentations in alcohol dependence: age at onset mattersJ Stud Alcohol Drugs201172575276221906503
  • Le StratYGrantBFRamozNGorwoodPA new definition of early age at onset in alcohol dependenceDrug Alcohol Depend20101081–2434820018459
  • LiuICBlackerDLXuRFitzmauriceGTsuangMTLyonsMJGenetic and environmental contributions to age of onset of alcohol dependence symptoms in male twinsAddiction200499111403140915500593
  • CloningerCRSigvardssonSGilliganSBvon KnorringALReichTBohmanMGenetic heterogeneity and the classification of alcoholismAdv Alcohol Subst Abuse198873–43163066194
  • PomboSLeschOMThe alcoholic phenotypes among different multidimensional typologies: similarities and their classification proceduresAlcohol Alcohol2009441465418832138
  • JohnsonBACloningerCRRoacheJDBordnickPSRuizPAge of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient populationAm J Addict200091172710914290
  • Buydens-BrancheyLBrancheyMHNoumairDAge of alcoholism onset. I. Relationship to psychopathologyArch Gen Psychiatry19894632252302919951
  • CloningerCRNeurogenetic adaptive mechanisms in alcoholismScience198723648004104162882604
  • CloningerCRThe psychobiological regulation of social cooperationNat Med1995176236247585135
  • StorvikMHaukijärviTTupalaETiihonenJCorrelation between the SERT binding densities in hypothalamus and amygdala in Cloninger type 1 and 2 alcoholicsAlcohol Alcohol2008431253018039673
  • TupalaEHallHBergströmKDifferent effect of age on dopamine transporters in the dorsal and ventral striatum of controls and alcoholicsSynapse200348420521112687640
  • HallikainenTSaitoTLachmanHMAssociation between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behaviorMol Psychiatry19994438538810483057
  • ChungIWKimHSribneyWTryptophan hydroxylase polymorphism is associated with age of onset of alcoholism related behaviorsAlcohol20053611316257348
  • ThompsonMDKennaGAVariation in the serotonin transporter gene and alcoholism: risk and response to pharmacotherapyAlcohol Alcohol201651216417126311211
  • BerglundKFahlkeCBerggrenUErikssonMBalldinJPersonality profile in type I alcoholism: long duration of alcohol intake and low serotonergic activity are predictive factors of anxiety pronenessJ Neural Transm200611391287129816463118
  • Fils-AimeMLEckardtMJGeorgeDTBrownGLMeffordILinnoilaMEarly-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholicsArch Gen Psychiatry19965332112168611057
  • SwannACJohnsonBACloningerCRChenYRRelationships of plasma tryptophan availability to course of illness and clinical features of alcoholism: a preliminary studyPsychopharmacology1999143438038410367555
  • SullivanJLBaenzigerJCWagnerDLRauscherFPNurnbergerJIHolmesJSPlatelet MAO in subtypes of alcoholismBiol Psychiatry19902789119222331498
  • RoacheJDWangYAit-DaoudNJohnsonBAPrediction of serotonergic treatment efficacy using age of onset and type A/B typologies of alcoholismAlcohol Clin Exp Res20083281502151218565156
  • KranzlerHRPierucci-LaghaAFeinnRHernandez-AvilaCEffects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label studyAlcohol Clin Exp Res20032771150115512878921
  • PettinatiHMVolpicelliJRKranzlerHRLuckGRukstalisMRCnaanASertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtypeAlcohol Clin Exp Res20002471041104910924008
  • KranzlerHRBurlesonJABrownJBaborTFFluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholicsAlcohol Clin Exp Res1996209153415418986200
  • LemarquandDPihlROBenkelfatCSerotonin and alcohol intake, abuse, and dependence: Clinical evidenceBiol Psychiatry19943653263377993959
  • BarnesNMSharpTA review of central 5-HT receptors and their functionNeuropharmacology19993881083115210462127
  • ThompsonMDNoble-TophamSPercyMEAndradeDMEbersGCChromosome 1p36 in migraine with aura: association study of the 5HT(1D) locusNeuroreport2012231454822107845
  • O’DellLEParsonsLHSerotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levelsJ Pharmacol Exp Ther2004311271171915226384
  • CrabbeJCPhillipsTJFellerDJElevated alcohol consumption in null mutant mice lacking 5–HT1B serotonin receptorsNat Genet1996141981018782828
  • FishEWMcKenzie-QuirkSDBannaiMMiczekKA5-HT(1B) receptor inhibition of alcohol-heightened aggression in mice: comparison to drinking and runningPsychopharmacology2008197114515618071678
  • LappalainenJLongJCEggertMLinkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populationsArch Gen Psychiatry199855119899949819067
  • SunHFChangYTFannCSAssociation study of novel human serotonin 5-HT(1B) polymorphisms with alcohol dependence in Taiwanese HanBiol Psychiatry2002511189690112022963
  • HasegawaYHiguchiSMatsushitaSMiyaokaHAssociation of a polymorphism of the serotonin 1B receptor gene and alcohol dependence with inactive aldehyde dehydrogenase-2J Neural Transm2002109451352111956970
  • SoykaMPreussUWKollerGZillPBondyBAssociation of 5-HT1B receptor gene and antisocial behavior in alcoholismJ Neural Transm2004111110110914714219
  • DuanJSandersARMolenJEPolymorphisms in the 5′-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expressionMol Psychiatry200381190191014593427
  • KranzlerHRHernandez-AvilaCAGelernterJPolymorphism of the 5-HT1B receptor gene (HTR1B): strong within-locus linkage disequilibrium without association to antisocial substance dependenceNeuropsychopharmacology200226111512211751038
  • SanderTOstapowiczASamochowiecJEvaluation of an allelic association of the serotonin 5-HT1B G681C polymorphism with antisocial alcoholism in the German populationAddict Biol20005216717220575831
  • SinhaRCloningerCRParsianALinkage disequilibrium and haplotype analysis between serotonin receptor 1b gene variations and subtypes of alcoholismAm J Med Genet B Neuropsychiatr Genet2003121B1838812898580
  • JensenKPCovaultJConnerTSTennenHKranzlerHRFurneauxHMA common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviorsMol Psychiatry200914438138918283276
  • ContiniVBertuzziGPPolinaERA haplotype analysis is consistent with the role of functional HTR1B variants in alcohol dependenceDrug Alcohol Depend20121221–210010422005095
  • PlemenitasAKastelicMO PorcelliSSerrettiADolžanVKores PlesnicarBAlcohol dependence and genetic variability in the serotonin pathway among currently and formerly alcohol-dependent malesNeuropsychobiology2015721576426352193
  • CookEHFletcherKEWainwrightMMarksNYanSYLeventhalBLPrimary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptorJ Neurochem19946324654698035173
  • MercadoCPKilicFMolecular mechanisms of SERT in platelets: regulation of plasma serotonin levelsMol Interv201010423124120729489
  • RuchkinVVKoposovRAaf KlintebergBOrelandLGrigorenkoELPlatelet MAO-B, personality, and psychopathologyJ Abnorm Psychol200511447748216117585
  • SerebruanyVLEl MouelhiMPfannkucheHJRoseKMarroMAngiolilloDJInvestigations on 5-HT4 receptor expression and effects of tegaserod on human platelet aggregation in vitroAm J Ther201017654355219797939
  • StratzCTrenkDBhatiaHSValinaCNeumannFJFiebichBLIdentification of 5-HT3 receptors on human platelets: increased surface immunoreactivity after activation with adenosine diphosphate (ADP) and thrombin receptor-activating peptide (TRAP)Thromb Haemost200899478478618392340
  • ZhangZJWangDManSCPlatelet 5-HT(1A) receptor correlates with major depressive disorder in drug-free patientsProg Neuropsychopharmacol Biol Psychiatry201453747924657886
  • Mück-ŠelerDPivacNSerotoninPeriod Biol20111132941
  • MassotORousselleJCFillionMPJanuelDPlantefolMFillionG5-HT1B receptors: a novel target for lithium. Possible involvement in mood disordersNeuropsychopharmacology199921453054110481837
  • WarkentinTEArnoldDMNaziIKeltonJGThe platelet serotonin-release assayAm J Hematol201590656457225775976
  • OrelandLPlatelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrectionNeurotoxicol2004251–27989
  • Yubero-LahozSRobledoPFarréMde LatorreRTorreRPlatelet SERT as a peripheral biomarker of serotonergic neurotransmission in the central nervous systemCurr Med Chem201320111382139623409709
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashington DCAmerican Psychiatric Press1994
  • PivacNMück-SelerDBarisićIJakovljevićMPuretićZPlatelet serotonin concentration in dialysis patients with somatic symptoms of depressionLife Sci200168212423243311350013
  • LowryOHRosebroughNJFarrALRandallRJProtein measurement with the Folin phenol reagentJ Biol Chem1951193126527514907713
  • MillerSADykesDDPoleskyHFA simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Res198816312153344216
  • FaulFErdfelderELangAGBuchnerAG*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciencesBehav Res Methods200739217519117695343
  • SempereLFFreemantleSPitha-RoweIMossEDmitrovskyEAmbrosVExpression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiationGenome Biol200453R1315003116
  • SmalheiserNRLugliGRizaviHSMicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessnessInt J Neuropsychopharmacol201114101315132521275079
  • FurayARNeumaierJFMullenixATKaiyalaKKSandygrenNKHoplightBJOverexpression of 5-HT(1B) mRNA in nucleus accumbens shell projection neurons differentially affects microarchitecture of initiation and maintenance of ethanol consumptionAlcohol2011451193220843634
  • HoplightBJSandygrenNANeumaierJFIncreased expression of 5-HT1B receptors in rat nucleus accumbens via virally mediated gene transfer increases voluntary alcohol consumptionAlcohol2006382737916839853
  • BannaiMFishEWFaccidomoSMiczekKAAnti-aggressive effects of agonists at 5-HT1B receptors in the dorsal raphe nucleus of micePsychopharmacology2007193229530417440711
  • DragoAAlboniSBrunelloNNicolettaBde RonchiDSerrettiAHTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memoryEur J Clin Pharmacol201066152719809810
  • SariYSerotonin1B receptors: from protein to physiological function and behaviorNeurosci Biobehav Rev200428656558215527863
  • BergKAClarkeWPRegulation of 5-HT(1A) and 5-HT(1B) receptor systems by phospholipid signaling cascadesBrain Res Bull200156547147711750792
  • TournoisCMutelVManivetPLaunayJMKellermannOCrosstalk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolismJ Biol Chem19982732817498175039651340
  • MontañezSMunnJLOwensWAHortonREDawsLC5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO miceNeurochem Int20147312713124246466
  • BaillyDVignauJLauthBPlatelet serotonin decrease in alcoholic patientsActa Psychiatr Scand199081168722330832
  • PivacNMück-SelerDMustapićMNenadić-SviglinKKozarić-KovacićDPlatelet serotonin concentration in alcoholic subjectsLife Sci200476552153115556165
  • SchmidtLGDufeuPHeinzAKuhnSRommelspacherHSerotonergic dysfunction in addiction: effects of alcohol, cigarette smoking and heroin on platelet 5-HT contentPsychiatry Res19977231771859406907
  • JavorsMTiouririneMPrihodaTPlatelet serotonin uptake is higher in early-onset than in late-onset alcoholicsAlcohol Alcohol200035439039310906007
  • LoweryCLElliottCCooperACigarette smoking-associated alterations in serotonin/adrenalin signaling pathways of plateletsJ Am Heart Assoc201765e00546528522678
  • Nenadic-SviglinKNedicGNikolacMSuicide attempt, smoking, comorbid depression, and platelet serotonin in alcohol dependenceAlcohol201145320921621167673
  • PatkarAAGopalakrishnanRBerrettiniWHWeinsteinSPVergareMJLeoneFTDifferences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokersPsychopharmacology2003166322122712589524
  • FowlerJSVolkowNDWangGJInhibition of monoamine oxidase B in the brains of smokersNature199637965677337368602220
  • FowlerJSVolkowNDWangGJBrain monoamine oxidase A inhibition in cigarette smokersProc Natl Acad Sci U S A1996932414065140698943061
  • BerlinIAnthenelliRMMonoamine oxidases and tobacco smokingInt J Neuropsychopharm20014013342
  • WhitfieldJBPangDBucholzKKMonoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathologyPsychol Med200030244345410824664